ASSESSING RISK OF BIAS IN RANDOMISED CLINICAL TRIALS INCLUDED IN COCHRANE REVIEWS: THE WHY IS EASY, THE HOW IS A CHALLENGE by Hrobjartsson, A, Boutron, I, Turner, L, Altman, D, Moher, D

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. by Chan, A, Hróbjartsson, A, Haahr, M, Gøtzsche, P, Altman, D

The evolution of assessing bias in Cochrane systematic reviews of interventions: celebrating methodological contributions of the Cochrane Collaboration. by Turner, L, Boutron, I, Hróbjartsson, A, Altman, D, Moher, D

Assessing risk of bias in studies that evaluate health care interventions: recommendations in the misinformation age by Page, M, Boutron, I, Hansen, C, Altman, D, Hróbjartsson, A

Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols. by Chan, A, Hróbjartsson, A, Jørgensen, K, Gøtzsche, P, Altman, D

Constraints on publication rights in industry-initiated clinical trials. by Gøtzsche, P, Hróbjartsson, A, Johansen, H, Haahr, M, Altman, D, Chan, A

Kontakt til udvalgene for videnskabelig uredelighed er det logiske skridt: Svar by Gøtzsche, P, Hróbjartsson, A, Johansen, H, Haahr, M, Altman, D, Chan, A

Ghost authorship in industry-initiated randomised trials. by Gøtzsche, P, Hróbjartsson, A, Johansen, H, Haahr, M, Altman, D, Chan, A

Videnskabelig uredelighed by Gøtzsche, P, Hróbjartsson, A, Johansen, H, Haahr, M, Altman, D, Chan, A

Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study. by Pildal, J, Chan, A, Hróbjartsson, A, Forfang, E, Altman, D, Gøtzsche, P

Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. by Pildal, J, Hróbjartsson, A, Jørgensen, K, Hilden, J, Altman, D, Gøtzsche, P

Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory. by Hróbjartsson, A, Pildal, J, Chan, A, Haahr, M, Altman, D, Gøtzsche, P

A new classification of spin in systematic reviews and meta-analyses was developed and ranked according to the severity by Yavchitz, A, Ravaud, P, Altman, DG, Moher, D, Hrobjartsson, A, Lasserson, T, Boutron, I

An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials by Hopewell, S, Boutron, I, Chan, A-W, Collins, GS, de Beyer, JA, Hróbjartsson, A, Nejstgaard, CH, Østengaard, L, Schulz, KF, Tunn, R, Moher, D

Methods used to develop the SPIRIT 2024 and CONSORT 2024 Statements by Tunn, R, Boutron, I, Chan, A-W, Collins, GS, Hróbjartsson, A, Moher, D, Schulz, KF, de Beyer, JA, Hansen Nejstgaard, C, Østengaard, L, Hopewell, S

Systematic review adherence to methodological or reporting quality by Pussegoda, K, Turner, L, Garritty, C, Mayhew, A, Skidmore, B, Stevens, A, Boutron, I, Sarkis-Onofre, R, Bjerre, L, Hróbjartsson, A, Altman, D, Moher, D

Identifying approaches for assessing methodological and reporting quality of systematic reviews: a descriptive study by Pussegoda, K, Turner, L, Garritty, C, Mayhew, A, Skidmore, B, Stevens, A, Boutron, I, Sarkis-Onofre, R, Bjerre, LM, Hróbjartsson, A, Altman, DG, Moher, D

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. by Chan, A, Tetzlaff, J, Gøtzsche, P, Altman, D, Mann, H, Berlin, J, Dickersin, K, Hróbjartsson, A, Schulz, K, Parulekar, W, Krleza-Jeric, K, Laupacis, A, Moher, D

Development of a topic‐specific bibliographic database supporting the updates of SPIRIT 2013 and CONSORT 2010 by Østengaard, L, Barrientos, A, Boutron, I, Chan, A, Collins, G, Hopewell, S, Moher, D, Nejstgaard, CH, Schulz, KF, Speich, B, Tang, E, Tunn, R, Watanabe, N, Xu, C, Hróbjartsson, A

SPIRIT 2013 statement: defining standard protocol items for clinical trials. by Chan, A, Tetzlaff, J, Altman, D, Laupacis, A, Gøtzsche, P, Krleža-Jerić, K, Hróbjartsson, A, Mann, H, Dickersin, K, Berlin, J, Doré, C, Parulekar, W, Summerskill, W, Groves, T, Schulz, K, Sox, H, Rockhold, F, Rennie, D, Moher, D